Regulatory News
Thursday, December 8, 2016
UPDATE 1-EU regulator accepts Sanofi/Regeneron's Dupixent product for review
* Product aimed at treating eczema
(Adds detail, background)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment